Shelley MacNeil
Tempus Labs (United States)(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Angiogenesis and VEGF in Cancer, Estrogen and related hormone effects, HER2/EGFR in Cancer Research, Bioinformatics and Genomic Networks
Most-Cited Works
- → Clinical validation of the tempus xT next-generation targeted oncology sequencing assay(2019)228 cited
- → Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes(2017)19 cited
- → Inferring pathway dysregulation in cancers from multiple types of omic data(2015)13 cited
- → The value of genomics in dissecting the RAS-network and in guiding therapeutics for RAS-driven cancers(2016)10 cited
- → Dissecting cancer using computational pathway-analysis(2018)1 cited
- → Additional file 3: of Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes(2017)
- → Additional file 4: of Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes(2017)
- → Additional file 2: of Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes(2017)
- → Additional file 5: of Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes(2017)